Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 21 citing articles:

Serotonin Receptors as Therapeutic Targets for Autism Spectrum Disorder Treatment
Ansoo Lee, Hyunah Choo, Byungsun Jeon
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6515-6515
Open Access | Times Cited: 30
Oxytocin and serotonin in the modulation of neural function: Neurobiological underpinnings of autism-related behavior
Feng Zhao, Hao Zhang, Peng Wang, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 24
Modulation of Serotonin Receptors in Neurodevelopmental Disorders: Focus on 5-HT7 Receptor
Jieon Lee, Diana Avramets, Byungsun Jeon, et al.
Molecules (2021) Vol. 26, Iss. 11, pp. 3348-3348
Open Access | Times Cited: 28
Acute administration of NLX-101, a Serotonin 1A receptor agonist, improves auditory temporal processing during development in a mouse model of Fragile X Syndrome
Tao Xin, Katilynne Croom, Adrian Newman‐Tancredi, et al.
Journal of Neurodevelopmental Disorders (2025) Vol. 17, Iss. 1
Open Access
Therapeutic Effects of Pharmacological Modulation of Serotonin Brain System in Human Patients and Animal Models of Fragile X Syndrome
Lucia Ciranna, Lara Costa
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2495-2495
Open Access
Evaluating the effect of R-Baclofen and LP-211 on autistic behavior of the BTBR and Fmr1-KO mouse models
Shirin Sharghi, Stefanie Flunkert, Magdalena Daurer, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 8
Knowledge-Based Design of Long-Chain Arylpiperazine Derivatives Targeting Multiple Serotonin Receptors as Potential Candidates for Treatment of Autism Spectrum Disorder
Enza Lacivita, Mauro Niso, Margherita Mastromarino, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 8, pp. 1313-1327
Open Access | Times Cited: 16
Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands
Gianfabio Giorgioni, Alessandro Bonifazi, Luca Botticelli, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2640-2706
Closed Access | Times Cited: 2
FPT, a 2-Aminotetralin, Is a Potent Serotonin 5-HT1A, 5-HT1B, and 5-HT1D Receptor Agonist That Modulates Cortical Electroencephalogram Activity in Adult Fmr1 Knockout Mice
Tanishka S. Saraf, Ryan P. McGlynn, Omkar Bhatavdekar, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 24, pp. 3629-3640
Open Access | Times Cited: 11
Spontaneous seizures in adult Fmr1 knockout mice: FVB.129P2-Pde6b+ Tyr Fmr1/J
Jessica Armstrong, Tanishka S. Saraf, Omkar Bhatavdekar, et al.
Epilepsy Research (2022) Vol. 182, pp. 106891-106891
Open Access | Times Cited: 8
Acute and Repeated Administration of NLX-101, a Selective Serotonin-1A Receptor Biased Agonist, Reduces Audiogenic Seizures in Developing Fmr1 Knockout Mice
Xuan‐Xiang Tao, Adrian Newman‐Tancredi, Mark A. Varney, et al.
Neuroscience (2022) Vol. 509, pp. 113-124
Open Access | Times Cited: 8
Chemical Modulators for Targeting Autism Spectrum Disorders: From Bench to Clinic
Songhyun Lim, Sanghee Lee
Molecules (2022) Vol. 27, Iss. 16, pp. 5088-5088
Open Access | Times Cited: 7
Evaluation of lorcaserin as an anticonvulsant in juvenile Fmr1 knockout mice
Tanishka S. Saraf, Daniel E. Felsing, Jessica Armstrong, et al.
Epilepsy Research (2021) Vol. 175, pp. 106677-106677
Open Access | Times Cited: 9
The Psychedelic N,N-Dipropyltryptamine Prevents Seizures in a Mouse Model of Fragile X Syndrome via a Mechanism that Appears Independent of Serotonin and Sigma1 Receptors
Richa Tyagi, Tanishka S. Saraf, Clinton E. Canal
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 10, pp. 1480-1491
Open Access | Times Cited: 3
Altered brain serotonin 5-HT1A receptor expression and function in juvenile Fmr1 knockout mice
Tanishka S. Saraf, Yi‐Ming Chen, Richa Tyagi, et al.
Neuropharmacology (2023) Vol. 245, pp. 109774-109774
Closed Access | Times Cited: 3
From circuits to behavior: Amygdala dysfunction in fragile X syndrome
Matthew N. Svalina, Regina M. Sullivan, Diego Restrepo, et al.
Frontiers in Integrative Neuroscience (2023) Vol. 17
Open Access | Times Cited: 2
In Vitro and In Silico Analysis of the Residence Time of Serotonin 5-HT7 Receptor Ligands with Arylpiperazine Structure: A Structure–Kinetics Relationship Study
Eduardo Penna, Mauro Niso, Sabina Podlewska, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 4, pp. 497-509
Closed Access | Times Cited: 3
Conformationally Selective 2-Aminotetralin Ligands Targeting the alpha2A- and alpha2C-Adrenergic Receptors
Nicholas Ronald Fragola, Brittany M. Brems, Munmun Mukherjee, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 10, pp. 1884-1895
Open Access | Times Cited: 1
Development of 2-Aminotetralin-Type Serotonin 5-HT1 Agonists: Molecular Determinants for Selective Binding and Signaling at 5-HT1A, 5-HT1B, 5-HT1D, and 5-HT1F Receptors
Ryan P. McGlynn, Meng Cui, Brittany Brems, et al.
ACS Chemical Neuroscience (2023) Vol. 15, Iss. 2, pp. 357-370
Open Access
The Need To Improve Reporting of the Pharmacological Action of New Molecules
Clinton E. Canal, Marcello Leopoldo
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 2, pp. 185-186
Closed Access
Tripping over the potential of psychedelics for autism
Alla Katsnelson
The Transmitter (2022)
Closed Access
Page 1

Scroll to top